Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Ophelia is not a typical SaaS or enterprise software product, but a U.S.-based online treatment service for people with opioid use disorder. Its core proposition is medication-assisted treatment (MAT) from home, delivered through video consultations, a dedicated care team, and prescription management for Suboxone® / buprenorphine + naloxone, helping patients reduce cravings and withdrawal symptoms. The site highlights appointments within 1–3 days, no need for in-person travel, and provides patient login and referral entry points.
Based on the collected content, the main modules include a free welcome call, online assessment, video clinical visits, Suboxone management, medication support for withdrawal-related symptoms, prescription routing to local pharmacies, care support seven days a week, and insurance coverage checks. Its care team consists of clinicians, nurses, care coordinators, and peer support staff. Common enterprise software capabilities such as third-party integrations, APIs, permission management, audit logs, and admin dashboards are not disclosed. The only confirmed software-adjacent capabilities are that Ophelia works with multiple insurance plans and supports sending prescriptions to local pharmacies.
Ophelia accepts a range of major insurance plans, including Medicaid. The site states that most patients pay less than $10 per month, covering video visits, Suboxone management, and ongoing support from a dedicated care team. Cash payment is also supported, but no specific cash pricing, plan tiers, or long-term contract details are provided. The free components mainly consist of the welcome call and insurance check, rather than a free plan or trial in the SaaS sense.
The main advantages are privacy, convenience, and no need to travel. Ophelia is best suited for people who want remote treatment for opioid use disorder and who do not require more advanced acute medical or psychiatric care. For patients with insurance coverage, the cost barrier may be relatively low. The drawbacks are that the service clearly depends on the U.S. healthcare, insurance, and prescription-regulation environment. The site does not specify state-level availability, cash pricing, HIPAA/SOC 2 security certifications, or enterprise-grade software integration details.
Access from China cannot be determined from the text alone. Even if the website is reachable, the service involves U.S. prescription medications, telehealth licensing, and the American insurance system, so practical use by users in China is likely to be highly restricted. In a China-based context, it should not be treated as a general-purpose SaaS procurement option. Users should prioritize locally compliant medical institutions, mental health centers, or qualified addiction medicine services.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on ophelia.com official site.
ophelia.com is an United States SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Unknown. Click "Visit Official Site" to reach ophelia.com directly.